PB1802: ACUTE PROMYELOCYTIC LEUKEMIA AND THROMBOSIS: HOW TO IDENTIFY THE HIGH‐RISK PATIENTS? von `Ben Salah, M., Bchir, M., Berred, R., Kharrat, R., Ben Abdennebi, Y., Aissaoui, L., Ben Lakhal, R., Ben neji, H., Meddeb, B.

Volltext

PB1803: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA: DEFINING HIGH RISK PATIENTS von `Ben Salah, M., Bchir, M., Berred, R., Kharrat, R., Aissaoui, L., Ben Abdennebi, Y., Ben Lakhal, R., Ben neji, H., Meddeb, B.

Volltext

P491: PREDICTIVE FACTORS OF DIFFERENTIATION SYNDROME IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA von Ben Salah, M., Bchir, M., Berred, R., Kharrat, R., Aissaoui, L., Ben Abdennebi, Y., Ben Lakhal, R., Ben neji, H., Meddeb, B.

Volltext

PB1824: IMPACT OF DAY 15 BONE MARROW ASPIRATION ON PREDICTION OF COMPLETE REMISSION AND RELAPSE IN ACUTE MYELOID LEUKEMIA von Kharrat, R., Charef, O., Berred, R., Chabaane, A., Sammoud, S., Bchir, M., Ben Lakhal, F., Feki, S., Borgi, W., Gouider, E., Amouri, A., Ayed, W., Ben Neji, H., Meddeb, B.

Volltext

PF478 DOES ESCALATED BEACOP‐DACARBAZINE DO THE SAME AS ESCALATED BEACOP‐PROCARBAZINE FOR UNFAVORABLE HODGKIN'S LYMPHOMA? von Mansouri, R., Kacem, K., Jabr, D., Bchir, M., Aissaoui, L., Berred, E., Kefi, S., Ben Néji, H., Achour, M., Ben Abdennebi, Y., Bahri, M., Meddeb, B., Ben Lakhal, R.

Volltext

PF478 DOES ESCALATED BEACOP‐DACARBAZINE DO THE SAME AS ESCALATED BEACOP‐PROCARBAZINE FOR UNFAVORABLE HODGKIN'S LYMPHOMA? von Mansouri, R., Kacem, K., Jabr, D., Bchir, M., Aissaoui, L., Berred, E., Kefi, S., Ben Néji, H., Achour, M., Ben Abdennebi, Y., Bahri, M., Meddeb, B., Ben Lakhal, R.

Volltext